type 1 diabetes

AstraZeneca's Farxiga scores FDA nod to cut risk of hospitalization for heart failure in diabetics
Endpoints
Mon, 10/21/19 - 10:08 am
AstraZeneca
Farxiga
type 1 diabetes
heart failure
Artificial pancreas outperforms current tech in type 1 diabetes
Pharmaforum
Fri, 10/18/19 - 09:44 am
type 1 diabetes
devices
NIH
artificial pancreas
Control-IQ
Sanofi paying Lexicon $260M to exit diabetes alliance
BioPharma Dive
Wed, 09/11/19 - 12:51 pm
Sanofi
Lexicon Pharmaceuticals
diabetes
type 1 diabetes
Zynquista
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Tue, 09/3/19 - 10:32 am
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
How one Boston startup rode the diabetes investment wave to raise $126M
Bizjournals
Tue, 08/13/19 - 10:23 am
Beta Bionics
type 1 diabetes
startups
devices
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sat, 07/27/19 - 01:58 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
AstraZeneca's Farxiga fails to get U.S. approval for Type-1 diabetes
Yahoo/Reuters
Mon, 07/15/19 - 09:58 am
AstraZeneca
FDA
Farxiga
type 1 diabetes
Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?
Forbes
Tue, 06/25/19 - 07:23 pm
type 1 diabetes
Eli Lilly
teplizumab
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
BioSpace
Mon, 06/10/19 - 04:26 pm
Povention Bio
clinical trials
type 1 diabetes
ADA
immunotherapy
A lifesaver with a catch: Powerful new cancer drugs can trigger diabetes — and no one is certain why
Stat
Wed, 05/29/19 - 09:41 am
type 1 diabetes
checkpoint inhibitors
cancer
Harvard-born diabetes startup Semma reports advances in turning stem cells into insulin producers
Fierce Biotech
Fri, 05/10/19 - 10:18 am
Semma Therapeutics
type 1 diabetes
Sanofi, Lexicon get complete response letter for Zynquista
BioCentury
Fri, 03/22/19 - 10:08 pm
Sanofi
Zynquista
Lexicon Pharmaceuticals
type 1 diabetes
FDA
AI Used to ID Risk of Heart Disease in Diabetes Study
Medical Devices and Diagnostics Industry
Sat, 03/9/19 - 12:33 pm
type 1 diabetes
artificial intelligence
heart disease
diagnostics
AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’
Fierce Biotech
Fri, 02/22/19 - 11:50 am
senescence
Venclexta
type 1 diabetes
AbbVie
JDRF Disappointed by UnitedHealthcare’s Preferred Medtronic Insulin Pump
Xtalks
Sat, 02/9/19 - 12:07 am
type 1 diabetes
JDRF
Medtronic
devices
MiniMed 670G
UnitedHealthcare
AstraZeneca’s Forxiga recommended for marketing authorization in EU
Pharmaceutical Business Review
Mon, 02/4/19 - 09:52 am
EMA
AstraZeneca
Forxiga
type 1 diabetes
CHMP
U.S. insulin costs per patient nearly doubled from 2012 to 2016: study
Reuters
Wed, 01/23/19 - 12:11 am
insulin
drug pricing
type 1 diabetes
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Fri, 01/18/19 - 10:26 am
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Daiichi Sankyo takes option on diabetes stem cell start-up
Pharmaforum
Sat, 01/12/19 - 11:30 am
Daiichi Sankyo
stem cells
Tokyo Institute of Technology
type 1 diabetes
OiDE BetaRevive
A vaccine for Type 1 diabetes? Provention Bio says a human trial is in sight
Fierce Biotech
Sat, 01/5/19 - 12:09 am
type 1 diabetes
Provention Bio
vaccines
PRV-101

Pages